Medicare AdvantageBilling CodesHigh impact
Update for CPT Codes 80320-80377: Effective 10/1/2026
Ambetter·NV·Coding
Effective date
Oct 1, 2026
We identified it
Aug 26, 2026
Summary
Effective October 1, 2026, CPT codes 80320-80377 (Definitive Drug Testing Procedures) will no longer be reimbursable by Ambetter Health. Billing teams must transition to G-series bundled laboratory codes for all drug testing claims to avoid denials.
Action Required
By September 30, 2026: Billing team must immediately identify all current uses of CPT codes 80320-80377 in the billing system and replace them with the appropriate G-series bundled laboratory codes. Update billing software to deny or reject claims using CPT 80320-80377 effective October 1, 2026. Audit all pending and scheduled drug testing orders to ensure correct code assignment before the effective date. Notify all providers and clinical staff of the code transition through staff meetings and written communication. Contact Ambetter Health Provider Relations Representative to confirm the exact G-series code mappings for your specific drug testing panels. Failure to transition to G-series codes will result in claim denials and loss of reimbursement for all definitive drug testing procedures.